HAYWARD, CALIFORNIA / ACCESS Newswire / February 12, 2025 / Biolog, Inc., a leading provider of cell-based microbial and phenotypic profiling products and multi ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...

The Canada Revenue Agency (CRA) has officially confirmed that Registered Clinical Counsellors (RCCs) in BC are now exempt from collecting GST on psychotherapy services. The ruling impacts 8,000+ RCCs, ...

Findings published in the paper currently undergoing peer review and accessible on MEDRXIV, demonstrate Nu.Q® NETs H3.1 is a promising novel biomarker for early mortality and org ...

NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a premier artificial intelligence (AI) company that is transforming clinical trials in the ...

Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical studyIndependent interim analysis of the E.mbrace phase 3 study finds that ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary ...

Frost & Sullivan recently assessed the clinical sample analysis services industry and, based on its findings, recognizes ...

Image Analysis Group (IAG), a leading imaging Clinical Research Organization (iCRO), today announced the release of their ...

Emergen Research Logo The Clinical Trial Logistics Market is expected to grow from an estimated USD 3915.5 million in 2024 to USD 8504.0 mi ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...